500 confirmed cases continued … Morning briefing of 400 600 people for next month



[ad_1]

Are 500 confirmed cases continuing?  ...

◆ Will 500 confirmed cases of Corona 19 emerge today?

The day before, the number of new coronavirus infections (Corona 19) was confirmed in the late 500s, showing signs of a third pandemic. The first pandemic was mainly in Daegu and Gyeongbuk, but this time, the group infection is mainly occurring in everyday spaces such as school, academy and religious facilities. It is also worrying that it is concentrating on metropolitan areas such as Seoul and Gyeonggi. Of the 583 new cases confirmed the day before, 225, or half, occurred in the metropolitan area. There were 66 confirmed cases related to the aerobic dance training academy in Gangseo-gu, Seoul, and 68 people tested positive over two days at the Yeoncheon Army Recruitment Training College in Gyeonggi-do. The cumulative number of confirmed cases related to the Hongdae New Church in Mapo-gu, Seoul, increased to 119.
Quarantine authorities estimate that there will be between 400 and 600 patients a day early next month. There are also forecasts that the first and second epidemic will be overcome in some cases with up to 1,000 confirmed cases. Even seasonally, the virus is prone to spreading. As indoor life increases in winter, the probability of spread is relatively higher than in other seasons.

◆ United States Shifts 6 Million People to Thanksgiving … “Covid-19 Outbreak in 1-2 Weeks”

A total of 5.95 million people have traveled by air since Thanksgiving 20 in the United States. Even on the 25th, the day before Thanksgiving, 107,967 people flew in by plane. This is the highest level since March 16, when the Corona 19 incident began in earnest. Currently, the number of new confirmed cases in the US for 23 consecutive days stands at about 100,000, and the figure daily deaths is also around 2,000. Authorities and experts predicted that the amount of confirmed corona19 and deaths will increase dramatically due to the change of the Great Thanksgiving Day.
The Centers for Disease Control and Prevention (CDC) predicted that 60,000 more will be sacrificed in the next three weeks, with the cumulative death toll reaching 321,000 by Dec. 19. “The death rate per day will double in the next ten days,” said Jonathan Reiner, a professor at the George Washington School of Medicine. “There will be about 4,000 deaths per day.”

Curebag, a German company that is developing a COVID-19 vaccine, said it is building an extensive manufacturing network to produce 300 million doses of the COVID-19 vaccine next year.  The photos are not related to the article.  / Photo = Getty Image Bank

Curebag, a German company developing a COVID-19 vaccine, said it is building an extensive manufacturing network to produce 300 million doses of the COVID-19 vaccine next year. The photos are not related to the article. / Photo = Getty Image Bank

◆ AstraZeneca CEO “Additional Corona Vaccine Global Clinical Trial”

A new vaccine against coronavirus infection (Corona 19) developed by the University of Oxford in the UK and AstraZeneca is expected to undergo further global clinical trials. “As we have found a way that works better, we have to prove it,” said Pascal Sorio AstraZeneca, CEO. Revealed. This is due to doubts about the reliability of the vaccine.
Previously, AstraZeneca and the University of Oxford announced that the average immunity effect was 70% as a result of initial data analysis from a phase 3 clinical trial of the vaccine they are developing. The prevention effect was 90% of the participants who took half the vaccine dose first and who took the full dose after one month. Prophylaxis for those who took the full dose at both doses was 62%. Researchers have yet to determine the cause of the different immune effects depending on the dose. It was also belatedly revealed that the participants who got half the serving here are all under the age of 55 and do not have an elderly population.

Russia’s second COVID-19 vaccine ‘breakthrough’

Phase 3 trials of Russia’s second COVID-19 vaccine have begun. This is an Epibakcorona vaccine developed by Vector, the National Center for Virus Research and Biotechnology, under the Supervisory Authority for Welfare and Protection of Consumer Rights (Rosport Revnadzor). Hospitals like Moscow will select 3,000 of the 4,000 volunteers to take the test. Authorities officially approved Epibakcorona in October. Epibakcorona became the second nationally approved vaccine after Sputinique V. The Epibaccorona vaccine has been administered as a synthetic antigen vaccine produced by synthesizing an antigen that is part of a protein that causes an immune response. The Sputnik V vaccine was a carrier vaccine made by inserting the Corona 19 virus gene into another virus that is harmless to the human body. Furthermore, in Russia, the Chumakov Center for Immunological Biology, under the local academy of sciences, is developing another COVID-19 vaccine, with phase 2 expected to end in December.

◆ Cold wind even during the day … It’s cold in the afternoon

The morning temperature in Seoul today is 4.2 degrees, 2 degrees higher than yesterday, but since the day, the temperature is expected to drop significantly as a cold wind blows. On the morning of the weekend, tomorrow, Seoul is expected to record -4 degrees Celsius, and the temperature will drop to -8 degrees Celsius. It can snow in the Gangwon region. As the afternoon rain expands south of Yeongdong, Gangwon-do, there is a chance that rain will accumulate as the rain turns to snow in the low-temperature mountains of Gangwon. Between tonight and tomorrow, there may be sporadic snowfalls and raindrops on the west coast of Jeolla and Jeju Island. In particular, snow can accumulate on Mount Halla and strong winds can break loose on the west coast and Jeju Island. The fine dust concentration is predicted to be good to normal in all areas, but Seoul, Gyeonggi-do, Chungbuk, Chungnam and Daegu may show low levels in the morning.

Until now, she was a reporter for Hankyung.

Ⓒ Hankyung.com prohibits unauthorized reproduction and redistribution

[ad_2]